Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

Autor: Öcal, Osman, Schinner, Regina, Schütte, Kerstin, de Toni, Enrico N., Loewe, Christian, van Delden, Otto, Vandecaveye, Vincent, Gebauer, Bernhard, Zech, Christoph J., Sengel, Christian, Bargellini, Irene, Gasbarrini, Antonio, Sangro, Bruno, Pech, Maciej, Malfertheiner, Peter, Ricke, Jens, Seidensticker, Max, Kettner, E., Amthauer, H., Cwikla, J., Walecki, J., Klümpen, H., Schott, E., Kolligs, F., Rosmorduc, O., Menu, Y., Leroy, V., Mayerle, J., Trumm, C., Bartenstein, P., Reiser, M., Berg, T., Moche, M., Bilbao, I., Gossner, L., Reimer, P., Popovic, P., Stabuc, B., Piasecki, P., Podgajny, Z., Sacco, R., Peck-Radosavljevic, M., Lammer, J., Maleux, G., Verslype, C., Rosenberg, C., Nitsche, D., Waldenberger, P., Vergniol, J., Cassinotto, C., Yalcin, S., Peynircioglu, B., Zavaglia, C., Rampoldi, A., Tran, A., Chevallier, P., Anty, R., Trautwein, C., Kuhl, C., Grazioli, L., Vogl, T., Trojan, J., Bartolozzi, C., Iezzi, R., Bronowicki, J. P., Palmer, D., Evans, J., Sharma, R., Weir, G., Hubner, R., Basu, B., Ross, P.
Přispěvatelé: Internal medicine, Apollo - University of Cambridge Repository, Kettner, E., Amthauer, H., Cwikla, J., Walecki, J., Klümpen, H., Schott, E., Kolligs, F., Rosmorduc, O., Menu, Y., Leroy, V., Mayerle, J., Trumm, C., Bartenstein, P., Reiser, M., Berg, T., Moche, M., Bilbao, I., Gossner, L., Reimer, P., Popovic, P., Stabuc, B., Piasecki, P., Podgajny, Z., Sacco, R., Peck-Radosavljevic, M., Lammer, J., Maleux, G., Verslype, C., Rosenberg, C., Nitsche, D., Waldenberger, P., Vergniol, J., Cassinotto, C., Yalcin, S., Peynircioglu, B., Zavaglia, C., Rampoldi, A., Tran, A., Chevallier, P., Anty, R., Trautwein, Christian, Kuhl, Christiane, Grazioli, L., Vogl, T., Trojan, J., Bartolozzi, C., Iezzi, R., Bronowicki, J. P., Palmer, D., Evans, J., Sharma, R., Weir, G., Hubner, R., Basu, B., Ross, P., Radiology and Nuclear Medicine, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, CCA -Cancer Center Amsterdam, Oncology, CCA - Cancer Treatment and Quality of Life
Rok vydání: 2022
Předmět:
Zdroj: Cancer Imaging, Vol 22, Iss 1, Pp 1-13 (2022)
Cancer imaging, 22(1):1. BioMed Central Ltd.
Öcal, O, Schinner, R, Schütte, K, de Toni, E N, Loewe, C, van Delden, O, Vandecaveye, V, Gebauer, B, Zech, C J, Sengel, C, Bargellini, I, Gasbarrini, A, Sangro, B, Pech, M, Malfertheiner, P, Ricke, J, Seidensticker, M, SORAMIC study group, Kettner, E, Amthauer, H, Cwikla, J, Walecki, J, Klümpen, H, Schott, E, Kolligs, F, Rosmorduc, O, Menu, Y, Leroy, V, Mayerle, J, Trumm, C, Bartenstein, P, Reiser, M, Berg, T, Moche, M, Bilbao, I, Gossner, L, Reimer, P, Popovic, P, Stabuc, B, Piasecki, P, Podgajny, Z, Sacco, R, Peck-Radosavljevic, M, Lammer, J, Maleux, G, Verslype, C, Rosenberg, C, Nitsche, D, Waldenberger, P, Vergniol, J, Cassinotto, C, Yalcin, S, Peynircioglu, B, Zavaglia, C, Rampoldi, A, Tran, A, Chevallier, P, Anty, R, Trautwein, C, Kuhl, C, Grazioli, L, Vogl, T, Trojan, J, Bartolozzi, C, Iezzi, R, Bronowicki, J P, Palmer, D, Evans, J, Sharma, R, Weir, G, Hubner, R, Basu, B & Ross, P 2022, ' Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib ', Cancer imaging, vol. 22, no. 1, 1 . https://doi.org/10.1186/s40644-021-00439-x
Cancer Imaging
Cancer imaging 22, 1 (2022). doi:10.1186/s40644-021-00439-x
Cancer imaging, 22(1):1. e-med
ISSN: 1740-5025
DOI: 10.17863/cam.81986
Popis: Cancer imaging 22, 1 (2022). doi:10.1186/s40644-021-00439-x
Published by BioMed Central, London
Databáze: OpenAIRE